Cargando…
Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice
Apolipoprotein M (apoM) is a recently identified human apolipoprotein that is associated with the formation of high-density lipoprotein (HDL). Studies have demonstrated that statins may affect the expression of apoM; however, the regulatory effects of statins on apoM are controversial. Furthermore,...
Autores principales: | Liu, Jian, Huang, Haoyue, Shi, Sheng, Wang, Xu, Yu, Yunsheng, Hu, Yanqiu, Sun, Jiacheng, Ren, Chuanlu, Yang, Junjie, Shen, Zhenya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176103/ https://www.ncbi.nlm.nih.gov/pubmed/30344653 http://dx.doi.org/10.3892/etm.2018.6694 |
Ejemplares similares
-
Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma
por: Morton, Richard E., et al.
Publicado: (2022) -
Apolipoprotein E genotypes of normal and hyperlipidemic subjects.
por: Kim, Y. S., et al.
Publicado: (1993) -
Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells
por: Delgado-Maroto, Virginia, et al.
Publicado: (2017) -
Compound K Attenuates the Development of Atherosclerosis in ApoE(−/−) Mice via LXRα Activation
por: Zhou, Li, et al.
Publicado: (2016) -
Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
por: Kalantari, Saeed, et al.
Publicado: (2014)